PAI Partners is in talks to buy SGD Pharma, a French supplier of COVID-19 vaccine vials, from China Jianyin Investment, reported Reuters. Citi and Rothschild advised PAI on the deal while Bank of America represented JIC.
Source: Reuters
PAI Partners in talks to buy SGD Pharma: Reuters
PAI Partners is in talks to buy SGD Pharma, a French supplier of COVID-19 vaccine vials, from China Jianyin Investment, reported Reuters.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.